Literature DB >> 25736377

Interrupting synoviolin play at the ER: a plausible action to elevate mitochondrial energetics and silence obesity.

Meghan S Soustek1, Pere Puigserver1.   

Abstract

Obesity is a global concern, which has been linked to increased risk for cardiovascular disease, type 2 diabetes, atherosclerosis,non-alcoholic fatty liver, and cancer. In this issue of The EMBO Journal,Fujita et al (2015) describe the role of an endoplasmic reticulum (ER)-resident E3ubiquitin ligase, synoviolin, and its ability to control body weight and energy expenditure by targeting PGC-1b, a transcriptional modulator of mitochondrial oxidative metabolism.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25736377      PMCID: PMC4406646          DOI: 10.15252/embj.201591240

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  11 in total

1.  Endoplasmic reticulum stress markers are associated with obesity in nondiabetic subjects.

Authors:  Neeraj K Sharma; Swapan K Das; Ashis K Mondal; Oksana G Hackney; Winston S Chu; Philip A Kern; Neda Rasouli; Horace J Spencer; Aiwei Yao-Borengasser; Steven C Elbein
Journal:  J Clin Endocrinol Metab       Date:  2008-08-26       Impact factor: 5.958

Review 2.  Signal integration in the endoplasmic reticulum unfolded protein response.

Authors:  David Ron; Peter Walter
Journal:  Nat Rev Mol Cell Biol       Date:  2007-07       Impact factor: 94.444

3.  Hrd1p/Der3p is a membrane-anchored ubiquitin ligase required for ER-associated degradation.

Authors:  N W Bays; R G Gardner; L P Seelig; C A Joazeiro; R Y Hampton
Journal:  Nat Cell Biol       Date:  2001-01       Impact factor: 28.824

4.  The E3 ligase synoviolin controls body weight and mitochondrial biogenesis through negative regulation of PGC-1β.

Authors:  Hidetoshi Fujita; Naoko Yagishita; Satoko Aratani; Tomoko Saito-Fujita; Saori Morota; Yoshihisa Yamano; Magnus J Hansson; Masato Inazu; Hiroko Kokuba; Katsuko Sudo; Eiichi Sato; Ko-Ichi Kawahara; Fukami Nakajima; Daisuke Hasegawa; Itsuro Higuchi; Tomoo Sato; Natsumi Araya; Chie Usui; Kenya Nishioka; Yu Nakatani; Ikuro Maruyama; Masahiko Usui; Naomi Hara; Hiroyuki Uchino; Eskil Elmer; Kusuki Nishioka; Toshihiro Nakajima
Journal:  EMBO J       Date:  2015-02-19       Impact factor: 11.598

Review 5.  Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator.

Authors:  Pere Puigserver; Bruce M Spiegelman
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

6.  Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation.

Authors:  Marc Uldry; Wenli Yang; Julie St-Pierre; Jiandie Lin; Patrick Seale; Bruce M Spiegelman
Journal:  Cell Metab       Date:  2006-05       Impact factor: 27.287

Review 7.  Endoplasmic reticulum stress and the inflammatory basis of metabolic disease.

Authors:  Gökhan S Hotamisligil
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 8.  Cellular bioenergetics as a target for obesity therapy.

Authors:  Yu-Hua Tseng; Aaron M Cypess; C Ronald Kahn
Journal:  Nat Rev Drug Discov       Date:  2010-06       Impact factor: 84.694

Review 9.  Synoviolin, protein folding and the maintenance of joint homeostasis.

Authors:  Naoko Yagishita; Satoshi Yamasaki; Kusuki Nishioka; Toshihiro Nakajima
Journal:  Nat Clin Pract Rheumatol       Date:  2008-02

10.  RING-finger type E3 ubiquitin ligase inhibitors as novel candidates for the treatment of rheumatoid arthritis.

Authors:  Naoko Yagishita; Satoko Aratani; Craig Leach; Tetsuya Amano; Yoshihisa Yamano; Ko Nakatani; Kusuki Nishioka; Toshihiro Nakajima
Journal:  Int J Mol Med       Date:  2012-09-18       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.